Empress Therapeutics co-founders from L-R: John Mendlein, Sabrina Yang, Jason Park, and Doug Cole.
June 21, 2023 06:00 AM EDTUpdated 06:27 AM
Financing
Startups
R&D

Flag­ship start­up Em­press Ther­a­peu­tics launch­es to search for small mol­e­cule drug leads in mi­cro­bial DNA

Ryan Cross

Senior Science Correspondent

Flag­ship’s lat­est start­up is bet­ting that a trea­sure trove of small mol­e­cule drugs is wait­ing to be dis­cov­ered right in­side our bod­ies — or rather, in­side …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times